ABOUT
Consultansy and distribution of Human Pharmaceuticals, Veterinary Vaccines. Turkey, Cyprus.
Özceada Consultancy is a niche consultancy, providing business development services to pharmaceutical companies and corporate financing services more widely in the healthcare sector.
The founding partner of this boutique consultancy has many years of top level management experience in Turkish pharma companies, as well as in consultancy experience in providing strategic advice to international pharma companies on product development and portfolio management.
Dr Selçuk Özceada PhD, MBA
Managing Director
Ozceada Consultancy and Trading Ltd Şti.
RESUME
SELÇUK ÖZCEADA
PhD, MBA, an entrepreneur with proven track record in scientific academia, business and public sectors.
A true multinational with 40 years of living and working experience in the UK, Norway, USA, Turkey and Cyprus on pharmaceuticals and healthcare.
BSc in Biochemistry at Kings College, London University. Masters in Clinical Biochemistry at leading medical schools of London University. Doctorate in Immunology from St. Thomas' Medical School, London University. MBA from Warwick University in the UK. Post-Doctoral fellow in the national Hospital of Norway in Oslo.
Owner of two companies dealing in human and veterinary pharmaceuticals wholesaling and distribution; and providing business development to international companies, specializing on biotechnology and vaccines. Dr Ozceada is also a core member of Global Healthcare Consulting group, an international business development consultancy established in Sweden.
Previously Dr Ozceada served as Under Secretary to the Ministry of Health, directing the provision of healthcare in North Cyprus; and as a pharmaceutical management consultant in UK, provided strategic advice to multinational pharmaceutical companies on product development. While doing his post-doctorate in Oslo, Dr. Ozceada played a pivotal role in assisting the Norwegian Department of Health in establishing a treatment and rehabilitation center for Norwegian rheumatic patients in Turkey.
Özceada has 23 publications in international journals on immunology, mainly on autoimmunity and antibody genetics. His four year postdoctoral studies at the National Hospital in Oslo led to his interest and hypothesis on immunogenetics of HIV infections and cancer.
PUBLICATIONS

Molecular analysis of human immunoglobulin heavy chain variable region associated determinants r ...

Characterization of naturally occurring autoantibodies against tumour necrosis factor-alpha (TNF ...

Three new cross-reacting idiotopes as markers for the products of two distinct human VH3 genes e ...

Heterogeneity of the TCR repertoire in synovial fluid T lymphocytes responding to BCG in a patie ...

Differentiation of human lambda I variable regions with a monoclonal antibody to a defined, germ ...

Limited heterogeneity of T cell receptor variable region gene usage in juvenile rheumatoid arthr ...







